Patents by Inventor Robert S. Schwartz

Robert S. Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969598
    Abstract: Systems and methods for controlling blood pressure via electrical stimulation of the heart are disclosed. Embodiments may include at least two different stimulation patterns, each configured to reduce blood pressure to a different degree, and may alternate between stimulation patterns based on the need of a patient, for example, alternating between day and night or between periods of strenuous and light activity. Some embodiments may take advantage of a slow baroreflex response that occurs after treatment is stopped, suspending treatment for extended periods, and then resuming treatment before blood pressure levels reach pretreatment values. Embodiments may control blood pressure by controlling atrial pressure and atrial stretch.
    Type: Grant
    Filed: August 9, 2022
    Date of Patent: April 30, 2024
    Assignee: BackBeat Medical, LLC
    Inventors: Yuval Mika, Darren Sherman, Robert S. Schwartz, Robert A. Van Tassel, Daniel Burkhoff
  • Publication number: 20240130628
    Abstract: Method and devices for treating a physiologic condition of a patient using measurements of pressure of an interstitial space of a patient as an indicator of required therapy.
    Type: Application
    Filed: January 13, 2022
    Publication date: April 25, 2024
    Applicant: NXT Biomedical, LLC
    Inventors: Robert S. Schwartz, Glen Rabito, Joseph Passman, Stanton J. Rowe, Abubaker Khalifa
  • Publication number: 20240123202
    Abstract: Methods and devices that prevent stasis in the LAA by either increasing the flow through the LAA or by closing off or sealing the LAA. Increasing the flow is accomplished through shunts, flow diverters, agitators, or by increasing the size of the ostium. Closing off the LAA is accomplished using seals or by cinching the LAA.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Applicant: NXT Biomedical, LLC
    Inventors: Glen Rabito, Joseph Passman, Robert C. Taft, Stanton J. Rowe, Robert S. Schwartz, Alexander Siegel
  • Publication number: 20240122470
    Abstract: Systems, devices, methods, and kits for monitoring one or more physiologic and/or physical signals from a subject are disclosed. A system including a head mounted display to monitor one or more physiologic signals from the face or head of the subject is disclosed. A method for analyzing an ocular parameter of the subject to determine a sympathetic and a parasympathetic outflow thereto is disclosed.
    Type: Application
    Filed: December 18, 2023
    Publication date: April 18, 2024
    Inventors: Landy Toth, Robert S. Schwartz
  • Patent number: 11957854
    Abstract: MVO is treated by introducing injectate into blood vessels affected by MVO at precise flow rates, while blocking retrograde flow, such that the natural pumping of the heart aids in forcing the injectate into the affected microvessels. Monitoring pressure distal of an occlusion balloon is used to determine treatment effectiveness and heart health.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: April 16, 2024
    Assignee: CorFlow Therapeutics AG
    Inventors: Robert S. Schwartz, Martin T. Rothman, Jon H. Hoem
  • Publication number: 20240115180
    Abstract: A method includes forming a film, forming a first pattern of two or more vias at least partially through the film, attaching the film to a first support structure, the first support structure comprising an adhesive layer formed over a first carrier, wherein attaching the film to the first support structure comprises bonding a first surface of the film to the adhesive layer of the first support structure, wherein the film is stretchable in at least a first direction along the first surface, and wherein the first carrier maintains the first pattern of vias within a given threshold distortion following a given process conducted after attaching the film to the first support structure.
    Type: Application
    Filed: December 18, 2023
    Publication date: April 11, 2024
    Inventors: Landy Toth, Robert S. Schwartz
  • Patent number: 11944538
    Abstract: A method of reducing regurgitation between native leaflets of an atrioventricular heart valve includes advancing a delivery catheter through a sheath, wherein the delivery catheter has a valve leaflet coaptation element mounted over a distal end portion. The coaptation element is positioned within the heart valve and is permitted to radially expand from a compressed configuration to an enlarged configuration for filling a gap between the native leaflets of the heart valve. After deployment, the position of the coaptation element is fixed relative to the heart valve, thereby reducing regurgitation between the native leaflets of the heart valve and improving heart function.
    Type: Grant
    Filed: May 20, 2022
    Date of Patent: April 2, 2024
    Assignee: EDWARDS LIFESCIENCES CORPORATION
    Inventors: Stanton J. Rowe, Robert S. Schwartz, Robert A. Van Tassel, Vivian Khalil, Erin M. Spinner, Neil S. Zimmerman, Alexander J. Siegel
  • Publication number: 20240090820
    Abstract: A system for modulating bladder function is disclosed. A system for evaluating the electrophysiological function of a bladder is disclosed. Methods for performing a controlled surgical procedure on a bladder are disclosed. A system for performing controlled surgical procedures in a minimally invasive manner is disclosed. An implantable device for monitoring and/or performing a neuromodulation procedure on a bladder is disclosed.
    Type: Application
    Filed: December 12, 2022
    Publication date: March 21, 2024
    Inventors: Landy Toth, Robert S. Schwartz, David Robins
  • Patent number: 11918807
    Abstract: A method includes receiving monitoring data from at least one sensing device coupled to a subject and analyzing the monitoring data to identify one or more physiologic parameters of the subject. The method also includes providing signaling to at least one stimulating device in response to the identified physiologic parameters, the signaling comprising instructions to apply a stimulus to the subject. The method further includes receiving additional monitoring data from the at least one sensing device, analyzing the additional monitoring data to identify one or more changes in the one or more physiologic parameters of the subject after application of the stimulus to the subject, and providing additional signaling to the at least one stimulating device, the additional signaling comprising instructions to modify the stimulus applied to the subject based on the identified changes in the one or more physiologic parameters.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: March 5, 2024
    Assignee: LifeLens Technologies, LLC
    Inventors: Landy Toth, Robert S. Schwartz, Beth Schwartz
  • Patent number: 11911186
    Abstract: A method includes obtaining monitoring data recorded by first and second devices, the first and second devices being attached to the subject at different first and second sties, respectively. The monitoring data comprises signals associated with at least one physiological parameter of the subject. The method also includes extracting one or more features of the signals recorded by the first and second devices during a transitionary period when the first and second devices simultaneously monitor the at least one physiological parameter of the subject. The method further includes generating at least one correlation parameter by analyzing the extracted features of the signals recorded by the first and second devices for at least a portion of the transitionary period, the at least one correlation parameter when applied to signals recorded by the second device at least partially compensating for relative changes in signals recorded by the first and second devices.
    Type: Grant
    Filed: June 7, 2022
    Date of Patent: February 27, 2024
    Assignee: LifeLens Technologies, LLC
    Inventors: Landy Toth, Robert S. Schwartz
  • Patent number: 11904120
    Abstract: Methods and devices that prevent stasis in the LAA by either increasing the flow through the LAA or by closing off or sealing the LAA. Increasing the flow is accomplished through shunts, flow diverters, agitators, or by increasing the size of the ostium. Closing off the LAA is accomplished using seals or by cinching the LAA.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: February 20, 2024
    Assignee: NXT Biomedical, LLC
    Inventors: Glen Rabito, Joseph Passman, Robert C. Taft, Stanton J. Rowe, Robert S. Schwartz, Alexander Siegel
  • Patent number: 11883103
    Abstract: Systems, devices, methods, and kits for monitoring one or more physiologic and/or physical signals from a subject are disclosed. A system including a head mounted display to monitor one or more physiologic signals from the face or head of the subject is disclosed. A method for analyzing an ocular parameter of the subject to determine a sympathetic and a parasympathetic outflow thereto is disclosed.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: January 30, 2024
    Assignee: Autonomix Medical, Inc.
    Inventors: Landy Toth, Robert S. Schwartz
  • Publication number: 20240024657
    Abstract: Described herein are improved blood pumping devices, including improved intra-aortic balloon pumps and ventricular assist devices. The pumping efficiency of either device may be improved with the use of one or more valves, counter pulsation balloons, non-compliant tubular structures, secondary pumping balloons, and similar components.
    Type: Application
    Filed: December 9, 2021
    Publication date: January 25, 2024
    Applicant: NXT Biomedical, LLC
    Inventors: Robert C. Taft, Alexander Siegel, Glen Rabito, Joseph Passman, Stanton J. Rowe, Elliot Howard, Jeremy Koehler, Robert S. Schwartz, Abubaker Khalifa
  • Patent number: 11872043
    Abstract: A method includes forming a film, forming a first pattern of two or more vias at least partially through the film, attaching the film to a first support structure, the first support structure comprising an adhesive layer formed over a first carrier, wherein attaching the film to the first support structure comprises bonding a first surface of the film to the adhesive layer of the first support structure, wherein the film is stretchable in at least a first direction along the first surface, and wherein the first carrier maintains the first pattern of vias within a given threshold distortion following a given process conducted after attaching the film to the first support structure.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: January 16, 2024
    Assignee: LifeLens Technologies, LLC
    Inventors: Landy Toth, Robert S. Schwartz
  • Publication number: 20230405336
    Abstract: Systems and methods for controlling blood pressure by controlling atrial pressure and atrial stretch are disclosed. In some embodiments, a stimulation circuit may be configured to deliver a stimulation pulse to at least one cardiac chamber of a heart of a patient, and at least one controller may be configured to execute delivery of one or more stimulation patterns of stimulation pulses to the at least one cardiac chamber, wherein at least one of the stimulation pulses stimulates the heart such that an atrial pressure resulting from atrial contraction of an atrium overlaps in time a passive pressure build-up of the atrium, such that an atrial pressure of the atrium resulting from the stimulation is a combination of the atrial pressure resulting from atrial contraction and the passive pressure build-up and is higher than an atrial pressure of the atrium would be without the stimulation, and such that the blood pressure of the patient is reduced.
    Type: Application
    Filed: June 14, 2023
    Publication date: December 21, 2023
    Inventors: Yuval Mika, Darren Sherman, Robert S. Schwartz, Robert A. Van Tassel, Daniel Burkhoff
  • Publication number: 20230381415
    Abstract: Methods and devices for the diagnosis and treatment of microvascular dysfunction, such as microvascular obstruction (MVO) and other dysfunctional diseases of the microvasculature of many organs, including the heart. The present subject matter provides novel devices and methods to successfully diagnose, restore patency, open and preserve flow, and limit reperfusion injury in organs and cases with microvascular dysfunction. The present subject matter provides apparatus and method to detect, measure and treat microvascular dysfunction in real time during scenarios such as invasive angiographic/therapeutic procedures. Such procedures include therapy for organ systems including the heart (acute myocardial infarction—primary percutaneous coronary intervention (PPCI)), brain stroke (CVA), bowel ischemia/infarction, pulmonary emboli/infarction, critical limb ischemia/infarction, renal ischemia/infarction, and others.
    Type: Application
    Filed: August 9, 2023
    Publication date: November 30, 2023
    Applicant: CorFlow Therapeutics AG
    Inventors: Robert S. SCHWARTZ, Jon Helge HOEM, Martin T. ROTHMAN
  • Publication number: 20230372684
    Abstract: A shunt is described that expands to an hourglass shape. As the shunt expands, both of its ends radially flare outwards relative to its middle section and the length of the shunt foreshortens, which causes the flared ends to engage the tissue surrounding a puncture or aperture within a patient's tissue.
    Type: Application
    Filed: August 4, 2023
    Publication date: November 23, 2023
    Applicant: NXT Biomedical, LLC
    Inventors: Robert C. Taft, Glen Rabito, Robert S. Schwartz
  • Patent number: 11786140
    Abstract: Devices and methods for determining fluid flow resistance at a targeted location in a bodily fluid vessel by monitoring changes in pressure gradients across the location while fluid flow is being manipulated by introducing infusate into the target area at different rates.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: October 17, 2023
    Assignee: CorFlow Therapeutics AG
    Inventor: Robert S. Schwartz
  • Publication number: 20230320877
    Abstract: Devices and methods of treating conditions cause or exacerbated by excessive fluid pressures or retentions, such as pulmonary hypertension, that involves shunting excessive fluid pressure from one bodily chamber or vessel to another bodily chamber or vessel.
    Type: Application
    Filed: June 13, 2023
    Publication date: October 12, 2023
    Applicant: NXT Biomedical, LLC
    Inventors: Robert S. Schwartz, Stanton J. Rowe, Robert C. Taft, Glen Rabito, Alexander Siegel, Joseph Passman
  • Patent number: 11752314
    Abstract: A shunt is described that expands to an hourglass shape. As the shunt expands, both of its ends radially flare outwards relative to its middle section and the length of the shunt foreshortens, which causes the flared ends to engage the tissue surrounding a puncture or aperture within a patient's tissue.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: September 12, 2023
    Assignee: NXT Biomedical, LLC
    Inventors: Robert C. Taft, Glen Rabito, Robert S. Schwartz